Secures third contract this year, reinforcing global competitiveness and expanding strategic partnerships SEOUL, South Korea and SYRACUSE, N.Y., Sept. 2, 2025 /PRNewswire/ — LOTTE BIOLOGICS (CEO James Park) today announced that it has entered a late-stage to commercial contract…
